In preclinical studies, curcumin was shown to inhibit the growth, invasion, and progression of human melanoma cells by several mechanisms [128,129,130,131] and was demonstrated to overcome chemoresistance in p53-mutant human melanoma cell lines, which are highly resistant to conventional chemotherapeutic agents [132]. This evidence concerns the gene TP53 and melanoma.